QARZIBA® is a monoclonal antibody that is specifically directed against the carbohydrate moiety of disialoganglioside 2 (GD2), which is overexpressed on neuroblastoma cells. Dinutuximab beta was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback